Stay updated with breaking news from Devices Division. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Gerresheimer, a leading provider of healthcare and beauty solutions and drug delivery systems for pharma, biotech and cosmetics, reports double-digit growth in revenues and adjusted EBITDA for FY
Consistent execution of strategy and strong fourth quarter performance has resulted in organic revenue growth of 16.2% for FY 2022Organic growth in adjusted EBITDA of 10.2% for FY 2022, ahead
EQS-News: Gerresheimer AG / Key word(s): Annual Results/Quarter ResultsGerresheimer AG: Gerresheimer 2022: Profitable growth company boosting revenue and adjusted EBITDA growth to double-digit levels 23.02.2023 / 07:00 CET/CESTThe issuer is solely responsible for the content of this announcement.Gerresheimer 2022: P...
/PRNewswire/ -- Gerresheimer AG, a leading provider of healthcare & beauty solutions and drug delivery systems for pharma, biotech and cosmetics, reports...
Gerresheimer, a leading provider of healthcare and beauty solutions and drug delivery systems for pharma, biotech and cosmetics, confirms guidance for its financial year 2022 (FY22) after another